Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corti Biciron N vs Dexa-Gentamicin in external ocular inflammation
2004-000877-80Phase 3Completed
- Sponsor
- S&K Pharma
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of dexamethasone isonicotinate + oxytetracycline hydrochloride in External ocular inflammation (EOI) (2 arms), sponsored by S&K Pharma. Primary endpoint: Change in clinical sum score of key signs and symptoms. Started Aug 2004; status: completed.
02
Drugs
dexamethasone isonicotinate + oxytetracycline hydrochloride
03
Conditions
External ocular inflammation (EOI)
Beyond the preview
Go deeper on 2004-000877-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000877-80.